Adicet reports fourth quarter and full year 2020 financial results and provides business update

Menlo park, calif. and boston, march 11, 2021 (globe newswire) -- adicet bio, inc. (nasdaq: acet), a biotechnology company discovering and developing allogeneic gamma delta t cell therapies for cancer and other diseases, today reported financial results and provided a business update for the fourth quarter and full year ended december 31, 2020.

ACET Ratings Summary

ACET Quant Ranking